Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (NCT07737262) titled 'Prophylactic NAC to Improve Platelet Engraftment After Haploidentical Transplantation in Severe Aplastic Anemia Patients' on July 27.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Prevention. Masking: None (Open Label).

Primary Sponsor: Peking University People's Hospital

Condition: Aplastic Anemia

Intervention: Drug: N-acetylcysteine

Recruitment Status: Not recruiting

Phase: Phase 3

Date of First Enrollment: August 1, 2026

Target Sample Size: 142

To know more, visit https://clinicaltrials.gov/study/NCT07737262

Disclaimer: Cur...